The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia
Open accessAbstract
We analyzed the long-term outcome of 1011 patients treated in five successive clinical trials (Total Therapy Studies 11, 12, 13A, 13B, and 14) between 1984 and 1999. The event-free survival improved significantly (P=0.003) from the first two trials conducted in the 1980s to the three more recent trials conducted in the 1990s. Approximately 75% of patients treated in the 1980s and 80% in the 1990s were cured. Early intensive triple intrathecal therapy, together with more effective systemic therapy, including consolidation and reinduction treatment (Studies 13A and 13B) as well as dexamethasone (Study 13B), resulted in a very low rate of isolated central nervous system (CNS) relapse rate (<2%), despite the reduced use of cranial irradiation. Factors consistently associated with treatment outcome were age, leukocyte count, immunophenotype, DNA index, and minimal residual disease level after remission induction treatment. Owing to concerns about therapy-related secondary myeloid leukemia and brain tumors, in our current trials we reserve the use of etoposide for patients with refractory or relapsed leukemia undergoing hematopoietic stem cell transplantation, and cranial irradiation for those with CNS relapse. The next main challenge is to further increase cure rates while improving quality of life for all patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
The Statistical Analysis of Failure Time Data
Kalbfleisch, J. D., & Prentice, R. L. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781118032985 · Cited by 3,219
The Statistical Analysis of Failure Time Data
Klein, J. P. (1982) · Technometrics · doi:10.1080/00401706.1982.10487769 · Cited by 2,215
Treatment of Acute Lymphoblastic Leukemia
Pui, C.-H., & Evans, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052603 · Cited by 1,976
Self-citationPui, C.-H., Robison, L. L., & Look, A. T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60457-2 · Cited by 1,564
Self-citationDeletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808253 · Cited by 1,422
Self-citationTreating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215
Self-citationPui, C.-H., Relling, M. V., & Downing, J. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmra023001 · Cited by 1,185
Self-citationEarly T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
Coustan-Smith, E., Mullighan, C. G., Onciu, M., Behm, F. G., Raimondi, S. C., Pei, D., Cheng, C., Su, X., Rubnitz, J. E., Basso, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70314-0 · Cited by 1,019
Self-citationDen Boer, M. L., van Slegtenhorst, M., De Menezes, R. X., Cheok, M. H., Buijs-Gladdines, J. G., Peters, S. T., Van Zutven, L. J., Beverloo, H. B., Van der Spek, P. J., Escherich, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70339-5 · Cited by 930
Self-citationSmith, M., Arthur, D., Camitta, B., Carroll, A. J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E. L., Link, M., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.18 · Cited by 901
Self-citationRelling, M. V., Hancock, M. L., Rivera, G. K., Sandlund, J. T., Ribeiro, R. C., Krynetski, E. Y., Pui, C.-H., & Evans, W. E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2001 · Cited by 733
Self-citationAcute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia
Pui, C.-H., Ribeiro, R. C., Hancock, M. L., Rivera, G. K., Evans, W. E., Raimondi, S. C., Head, D. R., Behm, F. G., Mahmoud, M. H., Sandlund, J. T., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112123252402 · Cited by 713
Self-citationConventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic Leukemia
Evans, W. E., Relling, M. V., Rodman, J. H., Crom, W. R., Boyett, J. M., & Pui, C.-H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802193380803 · Cited by 492
Self-citationClinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
Coustan-Smith, E., Sancho, J., Hancock, M. L., Boyett, J. M., Behm, F. G., Raimondi, S. C., Sandlund, J. T., Rivera, G. K., Rubnitz, J. E., Ribeiro, R. C., et al. (2000) · Blood · doi:10.1182/blood.v96.8.2691 · Cited by 484
Self-citationPui, C.-H., Sandlund, J. T., Pei, D., Campana, D., Rivera, G. K., Ribeiro, R. C., Rubnitz, J. E., Razzouk, B. I., Howard, S. C., Hudson, M. M., et al. (2004) · Blood · doi:10.1182/blood-2004-04-1616 · Cited by 463
Self-citationExtended Follow-up of Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia
Pui, C.-H., Cheng, C., Leung, W., Rai, S. N., Rivera, G. K., Sandlund, J. T., Ribeiro, R. C., Relling, M. V., Kun, L. E., Evans, W. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035091 · Cited by 457
Self-citationImmunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
Coustan-Smith, E., Behm, F. G., Sanchez, J., Boyett, J. M., Hancock, M. L., Raimondi, S. C., Rubnitz, J. E., Rivera, G. K., Sandlund, J. T., Pui, C.-H., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10295-1 · Cited by 447
Self-citationSecondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid Leukemia
Pui, C.-H., Behm, F. G., Raimondi, S. C., Dodge, R. K., George, S. L., Rivera, G. K., Mirro, J., Kalwinsky, D. K., Dahl, G. V., Murphy, S. B., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210302 · Cited by 441
Self-citationHigh incidence of secondary brain tumours after radiotherapy and antimetabolites
Relling, M. V., Rubnitz, J. E., Rivera, G. K., Boyett, J. M., Hancock, M. L., Felix, C. A., Kun, L. E., Walter, A. W., Evans, W. E., & Pui, C.-H. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11079-6 · Cited by 411
Self-citationCurrent management and challenges of malignant disease in the CNS in paediatric leukaemia
Pui, C.-H., & Howard, S. C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70070-6 · Cited by 393
Self-citationRivera, G. K., Pui, C.-H., Abromowitch, M., Mirro, J., Ochs, J. S., Look, A. T., Murphy, S. B., Dahl, G. V., Kalwinsky, D. K., Simone, J. V., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)90733-6 · Cited by 376
Self-citationSatelite Symposium V, Meet-the-Professor Sessions I and II, Main Sessions I-IX
(2004) · Annals of Hematology · doi:10.1007/s00277-004-0850-2 · Cited by 365
Flohr, T., Schrauder, A., Cazzaniga, G., Panzer-Grümayer, R., van der Velden, V, Fischer, S., Stanulla, M., Basso, G., Niggli, F. K., Schäfer, B. W., et al. (2008) · Leukemia · doi:10.1038/leu.2008.5 · Cited by 361
Hijiya, N., Hudson, M. M., Lensing, S., Zacher, M., Onciu, M., Behm, F. G., Razzouk, B. I., Ribeiro, R. C., Rubnitz, J. E., Sandlund, J. T., et al. (2007) · JAMA · doi:10.1001/jama.297.11.1207 · Cited by 311
Self-citationCoustan-Smith, E., Sancho, J., Behm, F. G., Hancock, M. L., Razzouk, B. I., Ribeiro, R. C., Rivera, G. K., Rubnitz, J. E., Sandlund, J. T., Pui, C.-H., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0006 · Cited by 272
Self-citationRivera, G. K., Pinkel, D., Simone, J. V., Hancock, M. L., & Crist, W. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291801 · Cited by 263
Bürger, B., Zimmermann, M., Mann, G., Kühl, J., Löning, L., Riehm, H., Reiter, A., & Schrappe, M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.096 · Cited by 262
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia
Pui, C.-H., & Jeha, S. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2240 · Cited by 236
Self-citationYang, J. J. (2009) · JAMA · doi:10.1001/jama.2009.7 · Cited by 216
Pui, C.-H., Mahmoud, H. H., Rivera, G. K., Hancock, M. L., Sandlund, J. T., Behm, F. G., Head, D. R., Relling, M. V., Ribeiro, R. C., Rubnitz, J. E., et al. (1998) · Blood · doi:10.1182/blood.v92.2.411 · Cited by 209
Self-citationPharmacogenetics of outcome in children with acute lymphoblastic leukemia
Rocha, J. C. C., Cheng, C., Liu, W., Kishi, S., Das, S., Cook, E. H., Sandlund, J. T., Rubnitz, J., Ribeiro, R., Campana, D., et al. (2005) · Blood · doi:10.1182/blood-2004-11-4544 · Cited by 209
Self-citationGajjar, A., Harrison, P. L., Sandlund, J. T., Rivera, G. K., Ribeiro, R. C., Rubnitz, J. E., Razzouk, B., Relling, M. V., Evans, W. E., Boyett, J. M., et al. (2000) · Blood · doi:10.1182/blood.v96.10.3381 · Cited by 206
Self-citationAncestry and pharmacogenetics of antileukemic drug toxicity
Kishi, S., Cheng, C., French, D., Pei, D., Das, S., Cook, E. H., Hijiya, N., Rizzari, C., Rosner, G. L., Frudakis, T., et al. (2007) · Blood · doi:10.1182/blood-2006-10-054528 · Cited by 205
Self-citationPui, C.-H., Boyett, J., Rivera, G., Hancock, M., Sandlund, J., Ribeiro, R., Rubnitz, J., Behm, F., Raimondi, S., Gajjar, A., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401938 · Cited by 199
Self-citationResults of Therapy for Acute Lymphoblastic Leukemia in Black and White Children
Pui, C.-H. (2003) · JAMA · doi:10.1001/jama.290.15.2001 · Cited by 199
Self-citationMahmoud, H. H., Rivera, G. K., Hancock, M. L., Krance, R. A., Kun, L. E., Behm, F. G., Ribeiro, R. C., Sandlund, J. T., Crist, W. M., & Pui, C.-H. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290504 · Cited by 199
Self-citationMasson, E., Relling, M. V., Synold, T. W., Liu, Q., Schuetz, J. D., Sandlund, J. T., Pui, C., & Evans, W. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118409 · Cited by 198
Self-citationYang, J. J., Bhojwani, D., Yang, W., Cai, X., Stocco, G., Crews, K., Wang, J., Morrison, D., Devidas, M., Hunger, S. P., et al. (2008) · Blood · doi:10.1182/blood-2008-06-165027 · Cited by 194
Self-citationSynold, T. W., Relling, M. V., Boyett, J. M., Rivera, G. K., Sandlund, J. T., Mahmoud, H. H., Crist, W., Pui, C., & We, E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117552 · Cited by 194
Self-citationHomocysteine, Pharmacogenetics, and Neurotoxicity in Children With Leukemia
Kishi, S., Griener, J., Cheng, C., Das, S., Cook, E. H., Pei, D., Hudson, M., Rubnitz, J., Sandlund, J. T., Pui, C.-H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.056 · Cited by 190
Self-citationEtoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia
Relling, M., Yanishevski, Y., Nemec, J., Evans, W., Boyett, J., Behm, F., & Pui, C.-H. (1998) · Leukemia · doi:10.1038/sj.leu.2400928 · Cited by 188
Self-citationIncreased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1
Jeha, S., Pei, D., Raimondi, S. C., Onciu, M. M., Campana, D., Chen, C., Sandlund, J. T., Ribeiro, R. C., Rubnitz, J. E., Howard, S. C., et al. (2009) · Leukemia · doi:10.1038/leu.2009.42 · Cited by 154
Self-citationRelling, M. V., Boyett, J. M., Blanco, J. G., Raimondi, S. C., Behm, F. G., Sandlund, J. T., Rivera, G. K., Kun, L. E., Evans, W. E., & Pui, C. (2003) · Blood · doi:10.1182/blood-2002-08-2405 · Cited by 151
Self-citationCoustan‐Smith, E., Ribeiro, R. C., Stow, P., Zhou, Y., Pui, C., Rivera, G. K., Pedrosa, F. D. P. R., & Campana, D. (2006) · Blood · doi:10.1182/blood-2006-01-0066 · Cited by 133
Self-citationThiopurine methyltransferase in acute lymphoblastic leukemia
Relling, M. V., Pui, C., Cheng, C., & Evans, W. E. (2006) · Blood · doi:10.1182/blood-2005-08-3379 · Cited by 130
Self-citationSchmiegelow, K., Forestier, E., Kristinsson, J., Söderhäll, S., Vettenranta, K. K., Weinshilboum, R. M., Wesenberg, F., & On behalf of the Nordic Society of Paediatric Haematology and Oncology (NOPHO) (2008) · Leukemia · doi:10.1038/leu.2008.316 · Cited by 122
Pui, C., Simone, J. V., Hancock, M., We, E., Dl, W., Wp, B., Dahl, G. V. H., Rk, D., Ochs, J., & Abromowitch, M. (1992) · PubMed · Cited by 74
Self-citation
Cited by
Hunger, S. P., Lu, X., Devidas, M., Camitta, B. M., Gaynon, P. S., Winick, N. J., Reaman, G. H., & Carroll, W. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8018 · Cited by 1,180
De Ruysscher, D., Niedermann, G., Burnet, N. G., Siva, S., Lee, A. W. M., & Hegi-Johnson, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0064-5 · Cited by 868
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Pui, C.-H., Carroll, W. L., Meshinchi, S., & Arceci, R. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7405 · Cited by 842
Self-citationVora, A., Goulden, N., Wade, R., Mitchell, C., Hancock, J., Hough, R., Rowntree, C., & Richards, S. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70600-9 · Cited by 478
Lipshultz, S. E., Scully, R. E., Lipsitz, S. R., Sallan, S. E., Silverman, L. B., Miller, T. L., Barry, E. V., Asselin, B. L., Athale, U., Clavell, L. A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70204-7 · Cited by 446
Metadata
- Authors
- Pui, C. H., Pei, D., Sandlund, J. T., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., Campana, D., Kun, L. E., Jeha, S., Cheng, C., Howard, S. C., Metzger, M. L., Bhojwani, D., Downing, J. R., Evans, W. E., & Relling, M. V.
- Venue
- Leukemia
- Published
- 2009-12-10
- Volume
- 24
- Issue
- 2
- Pages
- 371-382
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2129291628
- Cited by
- 293
- References
- 49
- FWCI
- 26.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.